Skip to main content
T&R Biofab Co., Ltd logo

T&R Biofab Co., Ltd — Investor Relations & Filings

Ticker · 246710 ISIN · KR7246710008 KO Manufacturing
Open in API
Filings indexed 416 across all filing types
Latest filing 2020-03-25 Regulatory Filings
Country KR South Korea
Listing KO 246710

About T&R Biofab Co., Ltd

http://www.tnrbiofab.com/en/

T&R Biofab Co., Ltd. is a biomedical engineering company specializing in the development and commercialization of regenerative medical technologies. The company utilizes its proprietary 3D bioprinting technology to manufacture a range of products. Its primary offerings include 3D-printed, bioresorbable medical scaffolds designed to aid in the regeneration and reconstruction of tissues and organs. Other key business areas encompass bio-surgical solutions, the development of organoids and mini-tissues for research and therapeutic applications, and the use of human induced pluripotent stem cells (hiPSC).

Recent filings

Filing Released Lang Actions
단일판매ㆍ공급계약체결
Regulatory Filings Classification · 95% confidence The document is a formal regulatory disclosure regarding a 'Single Sale/Supply Contract' (단일판매ㆍ공급계약체결) by T&R Biofab. It details the contract value, counterparty, duration, and payment terms. In the context of Korean regulatory filings (DART), this type of material contract disclosure is classified as a general regulatory announcement that does not fit into specific categories like M&A or financial reports, thus falling under the RNS (Regulatory Filings) category.
2020-03-25 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is titled '정기주주총회결과' (Annual General Meeting Results) and provides a detailed breakdown of the voting outcomes for various agenda items (financial statement approval, articles of incorporation changes, stock option grants, and director/auditor compensation limits) from the meeting held on March 24, 2020. Since it reports the official results of shareholder votes at an Annual General Meeting, it falls under the 'Declaration of Voting Results & Voting Rights Announcements' category.
2020-03-24 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a regulatory filing titled '임원ㆍ주요주주 특정증권등 소유상황보고서' (Report on Ownership of Specific Securities by Executives and Major Shareholders). This is a standard South Korean regulatory disclosure (DART filing) where an executive (Jin Song-wan) reports a change in their shareholding of TNR Biofab. This type of filing is specifically categorized as 'Director's Dealing' (DIRS) as it details personal share transactions by a company director.
2020-03-17 Korean
단일판매ㆍ공급계약체결
Capital/Financing Update Classification · 95% confidence The document is a regulatory filing from a Korean company (T&R Biofab) announcing a 'Single Sale/Supply Contract' (단일판매ㆍ공급계약체결). This type of disclosure is a standard regulatory announcement regarding a specific business contract, which does not fit into categories like financial reports, dividends, or management changes. As it is a specific regulatory disclosure of a contract, it falls under the 'Regulatory Filings' category.
2020-03-16 Korean
[기재정정]감사보고서제출
Audit Report / Information Classification · 98% confidence The document is a regulatory filing from the Korea Exchange (KRX) system regarding the submission of an audit report ('감사보고서 제출'). It specifically details a correction ('정정신고') to a previously submitted audit report, including a table comparing the 'before' and 'after' figures for financial items. Since this is a formal regulatory filing providing audit-related financial data and corrections rather than the full annual report document itself, it falls under the Audit Report/Information category. FY 2019
2020-03-16 Korean
감사보고서제출
Audit Report / Information Classification · 98% confidence The document is a regulatory filing from a Korean company (T&R Biofab) titled 'Audit Report Submission' (감사보고서 제출). It provides the audit opinion (unqualified/appropriate), key financial data, and details regarding the audit process. While it contains financial data, it is a summary disclosure of the audit results rather than the full annual report (10-K) or a standalone audit report document (AR). In the context of Korean regulatory filings (DART/KIND), this specific format is a standard disclosure of audit results, which falls under the 'Audit Report / Information' category as it provides the audit opinion and financial summary. FY 2019
2020-03-13 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.